A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NCT07693751 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer (Locally Advanced or Metastatic)

Interventions

BIOLOGICAL: SOT109

Sponsor

SOTIO Biotech a.s.